TNFα regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation

被引:191
作者
Sata, M
Walsh, K [1 ]
机构
[1] Tufts Univ, St Elizabeths Hosp, Sch Med, Div Cardiovasc Res, Boston, MA 02135 USA
[2] Univ Massachusetts, Med Ctr, Dept Physiol, Worcester, MA 01655 USA
[3] Tufts Univ, Sackler Sch Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA
关键词
D O I
10.1038/nm0498-415
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is generally believed that the vascular endothelium serves as an inflammatory barrier by providing a nonadherent surface to leukocytes. Here, we report that Fas ligand (FasL) is expressed on vascular endothelial cells (ECs) and that it may function to actively inhibit leukocyte extravasation. TNF alpha downregulates FasL expression with an accompanying decrease in EC cytotoxicity toward co-cultured Fas-bearing cells. Local administration of TNF alpha to arteries down regulates endothelial Fast expression and induces mononuclear cell infiltration. Constitutive Fast expression markedly attenuates TNF alpha-induced cell infiltration and adherent mononuclear cells undergo apoptosis under these conditions. These findings suggest that endothelial Fast expression can negatively regulate leukocyte extravasation.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 37 条
[1]   L-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules [J].
Adams, MR ;
Jessup, W ;
Hailstones, D ;
Celermajer, DS .
CIRCULATION, 1997, 95 (03) :662-668
[2]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[3]  
BILLINGHAM ME, 1987, TRANSPLANT P, V19, P19
[4]   IN-VIVO BLOCKADE OF TUMOR NECROSIS FACTOR-A IN CHOLESTEROL-FED RABBITS AFTER CARDIAC TRANSPLANT INHIBITS ACUTE CORONARY-ARTERY NEOINTIMAL FORMATION [J].
CLAUSELL, N ;
MOLOSSI, S ;
SETT, S ;
RABINOVITCH, M .
CIRCULATION, 1994, 89 (06) :2768-2779
[5]  
EMESON EE, 1988, AM J PATHOL, V130, P369
[6]   FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192
[7]   Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape [J].
Hahne, M ;
Rimoldi, D ;
Schroter, M ;
Romero, P ;
Schreier, M ;
French, LE ;
Schneider, P ;
Bornand, T ;
Fontana, A ;
Lienard, D ;
Cerottini, JC ;
Tschopp, J .
SCIENCE, 1996, 274 (5291) :1363-1366
[8]  
HANSSON GK, 1989, AM J PATHOL, V135, P169
[9]   CULTURE OF HUMAN ENDOTHELIAL CELLS DERIVED FROM UMBILICAL VEINS - IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGICAL CRITERIA [J].
JAFFE, EA ;
NACHMAN, RL ;
BECKER, CG ;
MINICK, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (11) :2745-2756
[10]   REGIONAL ACCUMULATIONS OF T-CELLS, MACROPHAGES, AND SMOOTH-MUSCLE CELLS IN THE HUMAN ATHEROSCLEROTIC PLAQUE [J].
JONASSON, L ;
HOLM, J ;
SKALLI, O ;
BONDJERS, G ;
HANSSON, GK .
ARTERIOSCLEROSIS, 1986, 6 (02) :131-138